Progress against hepatitis C by 2030 is possible
Tuesday, January 29, 2019 - 18:00
in Health & Medicine
A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030 -- equal to an 80 percent reduction in incidence and a 60 percent reduction in deaths compared with 2015, according to the first study to model hepatitis C interventions globally.